Tranexamic Acid for Trauma Patients - More Lives to Save and Outcomes to Consider. (2023)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1056/nejme2305075
PubMed Identifier: 37314242
Publication URI: http://europepmc.org/abstract/MED/37314242
Type: Journal Article/Review
Volume: 389
Parent Publication: The New England journal of medicine
Issue: 2
ISSN: 0028-4793